- Home
- NRSN vs SNAL Comparison
NRSN vs SNAL Comparison
Compare NRSN & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- SNAL
- Stock Information
- Founded
- NRSN 2017
- SNAL 2000
- Country
- NRSN Israel
- SNAL United States
- Employees
- NRSN N/A
- SNAL N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- SNAL Computer Software: Prepackaged Software
- Sector
- NRSN Health Care
- SNAL Technology
- Exchange
- NRSN Nasdaq
- SNAL Nasdaq
- Market Cap
- NRSN 29.8M
- SNAL 33.5M
- IPO Year
- NRSN 2021
- SNAL 2022
- Fundamental
- Price
- NRSN $1.18
- SNAL $1.03
- Analyst Decision
- NRSN Buy
- SNAL
- Analyst Count
- NRSN 2
- SNAL 0
- Target Price
- NRSN $14.00
- SNAL N/A
- AVG Volume (30 Days)
- NRSN 243.1K
- SNAL 104.4K
- Earning Date
- NRSN 11-03-2025
- SNAL 11-12-2025
- Dividend Yield
- NRSN N/A
- SNAL N/A
- EPS Growth
- NRSN N/A
- SNAL N/A
- EPS
- NRSN N/A
- SNAL N/A
- Revenue
- NRSN N/A
- SNAL $91,041,290.00
- Revenue This Year
- NRSN N/A
- SNAL $13.87
- Revenue Next Year
- NRSN N/A
- SNAL $26.20
- P/E Ratio
- NRSN N/A
- SNAL N/A
- Revenue Growth
- NRSN N/A
- SNAL 24.25
- 52 Week Low
- NRSN $0.80
- SNAL $0.64
- 52 Week High
- NRSN $2.60
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- NRSN 44.09
- SNAL 50.64
- Support Level
- NRSN $1.15
- SNAL $0.96
- Resistance Level
- NRSN $1.30
- SNAL $1.05
- Average True Range (ATR)
- NRSN 0.07
- SNAL 0.09
- MACD
- NRSN -0.00
- SNAL -0.01
- Stochastic Oscillator
- NRSN 31.43
- SNAL 29.14
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.